Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
Midi Health Review
An in-depth look at Midi Health — virtual menopause and perimenopause care in all 50 states, and unusually for this category, in-network with most major PPO plans. That insurance pathway is the reason it earns a higher rating than its cash-pay competitors.
Midi Health
Insurance-Covered Menopause CareMidi Health is a virtual care platform built specifically around women's midlife health — perimenopause, menopause and hormonal wellness — operating in all 50 states with clinicians credentialed in menopause-specific care. It reached a reported $1 billion valuation in early 2026, which is context rather than a recommendation, but it does indicate a well-capitalised operation rather than a thin storefront.
The thing that genuinely separates it from the rest of the menopause telehealth category is insurance. Midi is in-network with most major PPO plans across the country, which matters enormously: the competing model is cash-pay compounded hormone therapy at $39–$93 a month with no insurance route at all. Where Midi is covered, you are getting menopause care through your existing benefits, with FDA-approved hormone therapy available rather than only compounded preparations.
Self-pay pricing, where insurance does not apply, is reported around $250 for an initial visit and $150 for follow-ups, with some programmes starting near $127/month. Reported Trustpilot sentiment sits around 4 out of 5 across 1,200-plus reviews, with praise focused on clinicians who take menopause seriously — which is the core problem this category exists to solve, since many women struggle to find a GP willing to engage with it at all.
The caveats: coverage varies by plan and deductibles and coinsurance still apply, so 'in-network' does not mean free. Midi is not enrolled with Medicaid or Medi-Cal and cannot treat those patients. Reported complaints centre on insurance-coverage confusion and slow communication. And it is not a GLP-1 provider — though hormonal change and metabolic change genuinely overlap in midlife, this is menopause care.
Affiliate disclosure: GLP1Drugs.org earns a commission if you sign up through the links on this page. It does not affect our rating. Details checked 29 July 2026.
Visit Midi HealthOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
50
States Served
PPO
In-Network Coverage
~$250
Self-Pay Initial Visit
4.0
Reported Trustpilot
Midi vs Cash-Pay Menopause Care
How an insurance-based menopause service compares to the compounded cash-pay model. Checked 29 July 2026.
| Midi Health | Cash-pay compounded (e.g. Winona) | |
|---|---|---|
| Insurance | In-network with most PPOs | None |
| Cost | Copay, or ~$250 initial self-pay | $39–$93/month |
| Hormone type | FDA-approved options available | Compounded, not FDA-approved |
| Live consultation | Yes, clinician visits | Often asynchronous messaging |
| States | All 50 | Frequently 15+ excluded |
| Medicaid / Medi-Cal | Not accepted | Not accepted |
That table is the argument for paying attention to Midi. The compounded cash-pay model is cheaper on a sticker-price basis and genuinely useful for women who cannot access care otherwise — but it means unapproved preparations, often no live consultation, and wide state exclusions. If your PPO covers Midi, you get FDA-approved hormone therapy from a clinician who specialises in menopause, for a copay. That is a better clinical proposition, and it is worth checking your plan before defaulting to the cheaper-looking option.
What's Included
Menopause-Trained Clinicians
Clinicians credentialed specifically in menopause and perimenopause care rather than general primary care
Insurance Billing
In-network with most major PPO plans nationally; coverage, deductibles and coinsurance vary by plan
FDA-Approved Hormone Therapy
Access to approved HRT products rather than only compounded preparations
All 50 States
National coverage, unlike most menopause telehealth services
Live Clinician Visits
Scheduled visits with a clinician rather than questionnaire-only asynchronous care
Broader Midlife Care
Coverage extending beyond hormones into wider midlife women's health concerns
Pros & Cons
Pros
- ✓In-network with most major PPO plans — the only menopause telehealth service we have reviewed with a real insurance pathway
- ✓Access to FDA-approved hormone therapy rather than only compounded 'bioidentical' preparations
- ✓Available in all 50 states, where competitors commonly exclude 15 or more
- ✓Clinicians credentialed specifically in menopause care, addressing a genuine gap in general practice
- ✓Live consultations rather than questionnaire-only asynchronous prescribing
- ✓Well capitalised, with a reported $1 billion valuation in early 2026
- ✓Reported Trustpilot average around 4.0 across 1,200-plus reviews
Cons
- ✕'In-network' does not mean free — deductibles, coinsurance and copays still apply and vary by plan
- ✕Not enrolled with Medicaid or Medi-Cal, so those patients cannot be treated
- ✕Self-pay pricing is substantially higher than cash-pay compounded competitors at around $250 initial and $150 per follow-up
- ✕Reported complaints centre on confusion about insurance coverage and slow communication
- ✕Not a GLP-1 provider and does not prescribe weight-loss medication
- ✕PPO focus means HMO and some other plan types may not be covered
Our Verdict
4.3 / 5 — the only menopause telehealth service we have reviewed with a genuine insurance pathway, FDA-approved hormone options and all-50-state coverage. Verify your plan first.
Rated as menopause care, not a GLP-1 provider. Midi solves the same access problem as the cash-pay compounded platforms — women unable to find a clinician who takes menopause seriously — but it solves it better: real insurance coverage, clinicians credentialed in menopause specifically, FDA-approved hormone therapy rather than only compounded preparations, live consultations, and all 50 states. If your PPO covers it, this is the option to check before defaulting to a cheaper-looking cash-pay service. The honest caveats are that coverage still involves deductibles, Medicaid patients are excluded, and self-pay pricing is high.
Visit Midi HealthFrequently Asked Questions
Does Midi Health take insurance?
Yes, and this is its main advantage. Midi is in-network with most major PPO plans across the US. Be precise about what that means though: in-network reduces what you pay, but deductibles, coinsurance and copays still apply depending on your plan, so your actual cost could be anywhere from a small copay to the full visit price if your deductible is unmet. Midi is not enrolled with Medicaid or Medi-Cal. Verify your own plan directly with your insurer before your first visit — coverage confusion is the single most common complaint reported about this service.
How much does it cost without insurance?
Reported self-pay pricing is around $250 for an initial visit and $150 for follow-ups, with some programmes starting near $127/month, checked 29 July 2026. That is considerably more than cash-pay compounded competitors charging $39–$93 a month — but you are buying live consultations with menopause-trained clinicians and access to FDA-approved hormone therapy, which is a different product.
Is FDA-approved hormone therapy better than compounded?
Generally yes, where a suitable approved product exists, and this is worth understanding before choosing a provider. 'Bioidentical' is a marketing term, not an FDA-recognised clinical category. Compounded hormone preparations are not FDA-approved and are not held to the same batch-consistency and testing requirements as approved drugs, and major professional bodies recommend approved products where one fits. Compounding is legitimately useful when you need a dose or formulation not commercially available, or react to an ingredient in an approved product — but it is not inherently safer or more natural.
Who should not use hormone therapy?
Hormone therapy is generally not appropriate for women with a history of breast cancer or other oestrogen-dependent cancer, unexplained vaginal bleeding, previous blood clots, stroke or heart attack, or active liver disease. Risk and benefit also depend heavily on your age and time since menopause began — the balance is generally more favourable starting near the onset of menopause than many years later. Common side effects include breast tenderness, bloating, mood changes, headaches and irregular bleeding. Discuss your own history with a clinician.
Why is menopause care on a GLP-1 site?
It came through our affiliate queue. There is a real overlap — metabolic rate, body composition and weight distribution all shift through perimenopause, and many women seeking weight treatment in midlife are also experiencing hormonal change — but Midi does not prescribe GLP-1 medication, and this review should not be read as suggesting it treats weight.
Ready to Get Started?
Verify your specific plan's coverage directly with your insurer before your first visit — insurance confusion is the most common complaint about this service.
Visit Midi HealthCompare Other GLP-1 Providers
See how other telehealth providers stack up.
Alan Meds
Top RatedAffordable compounded GLP-1s with board-certified physicians and straightforward pricing
Read Review →JumpstartMD
Comprehensive ProgramMedically supervised program with obesity medicine physicians, dietitians, and in-person options
Read Review →Boston Medical Group
Top RatedEstablished telehealth provider with physician oversight and transparent pricing
Read Review →Amazon One Medical
Brand-Name, No CompoundingFDA-approved Wegovy, Zepbound and Foundayo from $149/month cash, $25 with insurance and $50/month for eligible Medicare members — the first mainstream route to approved medication at prices that compete with compounded. We earn no commission from it
Read Review →CoreAge Rx
#1 RecommendedFlat-rate pricing for compounded semaglutide and tirzepatide with NABP-verified pharmacies
Read Review →BeyondMD
Top RatedBoard-certified physician-led care with comprehensive medical oversight
Read Review →Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Midi Health provides menopause and midlife women's health care; it does not prescribe GLP-1 medication and is unrelated to weight-loss treatment. Hormone therapy carries risks that depend on your age, time since menopause and personal and family history, and is generally avoided with a history of breast or other oestrogen-dependent cancer, unexplained vaginal bleeding, prior clots, stroke or heart attack, or active liver disease. Prescribing is subject to clinician assessment and is not guaranteed. Always consult a qualified healthcare provider.
Coverage Note: Checked 29 July 2026. In-network status, copays, deductibles and coinsurance vary by individual plan — verify directly with your insurer. Midi is not enrolled with Medicaid or Medi-Cal. Self-pay figures are as reported and subject to change.
Affiliate Disclosure: This site may receive compensation from affiliate partners, including Midi Health. This does not influence our editorial content or review ratings.